Eupraxia Pharmaceuticals Inc (EPRX) Technical Analysis
$5.81▲9.62%
Market is closed - opens 7 PM, 01 Jul 2025
Insights
- Eupraxia Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Eupraxia Pharmaceuticals stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Eupraxia Pharmaceuticals stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Eupraxia Pharmaceuticals stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 84.05 | Sell |
Stochastic | 91.64, 85.56 | Neutral |
Ultimate Oscillator | 70.41 | Sell |
Stochastic Relative Strength Index | 92.08, 89.82 | Neutral |
Moving Average Convergence Divergence | 0.23, 0.13 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.38 | Buy |
20 | 4.17 | Buy |
50 | 3.96 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.47 | Buy |
20 | 4.26 | Buy |
50 | 4.0 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.5 | Buy |
20 | 4.2 | Buy |
50 | 3.98 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.76 | Buy |
20 | 4.54 | Buy |
50 | 4.3 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.91 | Buy |
20 | 4.68 | Buy |
50 | 4.4 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 5.01 |
Resistance L2 | 4.84 |
Resistance L1 | 4.73 |
Pivot Point | 4.57 |
Support L1 | 4.45 |
Support L2 | 4.29 |
Support L3 | 4.18 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.